NX1NEXALIS THERAPEUTICS LTDMarket sensitive

First patient dosed in IRX-616a Phase 1 trial

Date and time
Announcement type
Company Update
Show details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASXOpen original PDFNX1 announcement history

Recent NX1 announcements